Navigation Links
SaltWorks, Inc. Advises Table Salt Alternatives
Date:3/31/2008

om, is still made the traditional way, by evaporating clean seawater in the sun and wind. To ensure his company's all-natural guarantee is upheld, Zoske personally inspects every family farm and village hand-harvesting the salt SaltWorks imports.

"Consumers deserve healthier ingredients in their food," stated Naomi Novotny, SaltWorks co-founder. "If more people knew the truth about table salt, I believe it would quickly go the way of trans fats. SaltWorks is urging everyone involved in the food industry - restaurants, grocery stores, food manufacturers, etc. - to stop needlessly exposing consumers to the adverse health effects of the chemical known as refined table salt. We're just asking everyone to season responsibly."

About SaltWorks, Inc.

SaltWorks is America's gourmet sea salt company, offering the world's finest brands of sea salt, including Artisan Salt Company, Fusion, Le Tresor and Pure Ocean. The company stocks over two million pounds of sea salt in 50 different varieties. SaltWorks prides itself on its approach to the sea salt business, focusing on traditional harvesting methods, sustainability, natural processes and quality. To learn more, visit http://www.seasalt.com.

Contact:

Naomi Novotny

SaltWorks, Inc.

800-353-7258

naomi@seasalt.com

http://www.seasalt.com

This release was issued through eReleases(TM). For more information, visit http://www.ereleases.com.


'/>"/>
SOURCE SaltWorks, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Russell Investment Group Advises Protalix Biotherapeutics of Index Adjustment
2. My Medicare Matters(TM) Advises Evaluating Your Current Medicare Part D Plan During Open Enrollment
3. Ranbaxy Receives Tentative Approval to Manufacture and Market Galantamine Tablets on an Exclusive Basis
4. Schering-Plough/Merck Pharmaceuticals Announce FDA Filing Acceptance of New Drug Application for Loratadine/Montelukast Tablet
5. JCI table of contents: Sept. 4, 2007
6. FDA Seeks to Regulate Complementary and Alternative Medicine; Products Such as Vegetable Juice Could Be Restricted for Medical Use
7. Actavis Launches Carvedilol Tablets in the U.S.
8. Mylan Announces Final FDA Approval for Carvedilol Tablets
9. Ranbaxy Gains Approval to Manufacture and Market Carvedilol Tablets in the U.S. Market
10. Actavis Launches Amlodipine Tablets in the U.S.
11. Implantable device designed to detect, stop seizures under study at MCG
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/21/2014)... Albany, New York (PRWEB) August 21, 2014 ... Transparency Market Research "Medical Fiber Optics Market-Global Industry Analysis, ... the global medical fiber optics market was valued at ... grow at a CAGR of 7.6% from 2013 to ... million in 2019. , The medical fiber optics market ...
(Date:8/21/2014)... According to a new market report published by ... Analysis, Size, Share, Growth, Trends and Forecast, 2012 - ... USD 236.1 million in 2011 and is estimated to ... at a CAGR of 6.3% from 2012 to 2018. ... http://www.transparencymarketresearch.com/fundus-cameras.html . , Fundus cameras market growth in recent ...
(Date:8/21/2014)... 21, 2014 The worlds of personal ... an exciting chance to grab free products. BaliniSports ... from Tom's of Maine with all qualifying purchases for ... our environmentally friendly yoga apparel is simply perfect,” said ... promotion between the two brands is intended to give ...
(Date:8/21/2014)... August 21, 2014 Tibet has long ... the mysterious mountaintop kingdom. Prayers flags whip in ... and the low rumble of chanting monks fill the ... of the world’, access to Tibet is challenging due ... foreign land can prove to be daunting for even ...
(Date:8/21/2014)... David Mullings’ new book, Things #Entrepreneurs ... collection of quotes from famous entrepreneurs to the not ... entrepreneurs on their challenging paths towards success. Earth Source ... of President and Founder Audrey Darrow alongside the bits ... celebrities such as Oprah Winfrey, Steve Jobs, and Richard ...
Breaking Medicine News(10 mins):Health News:Global Medical Fiber Optics Market: Industry Analysis, Size, Share, Growth, Trend and Forecast 2013 - 2019 2Health News:Global Medical Fiber Optics Market: Industry Analysis, Size, Share, Growth, Trend and Forecast 2013 - 2019 3Health News:Global Medical Fiber Optics Market: Industry Analysis, Size, Share, Growth, Trend and Forecast 2013 - 2019 4Health News:Fundus Cameras Market: Product Type- Mydriatic, Non-Mydriatic, Hybrid and ROP Cameras; End Users- Hospitals, Ophthalmology Clinics and Ophthalmic & Optometrist Offices 2Health News:Tom's of Maine Partner up with BaliniSports Yoga Apparel 2Health News:Earth Source Organics President Audrey Darrow Featured in New David Mullings Book 2
... BLU-MED Response Systems,announced today two new contract ... preparedness and surge capacity for hospitals and,public health ... District,Four and Suffolk County, NY., The first ... awarded by the Idaho Central District Health Department. ...
... of connecting with doctors in real time, speeding care, study ... patients report to doctors on their symptoms and side effects ... Even the sickest cancer patients are willing and capable of ... Cancer Center in New York City. , "Cancer care has ...
... Calif., Nov. 30 Omnicell, Inc.,(Nasdaq: OMCL ... acute healthcare,facilities, today announced that it has entered ... in an all cash transaction valued at,approximately $26 ... mobile cart technology that brings quality healthcare to ...
... a significantly slower rate of decline in lung function in ... study. , Researchers found that patients with cystic fibrosis ... percent reduction in loss of lung function compared to those ... a period of two to seven years. , It ...
... Specifically for Resource-Limited ... Global Procurement Consortium, UPPSALA, Sweden, November 30 ... an agreement with the Clinton,Foundation HIV/AIDS Initiative (CHAI). Under ... to members of CHAI,s,Procurement Consortium at a discounted price. ...
... AstraZeneca (NYSE:,AZN) today announced that the United States ... six-month period of,exclusivity to market ARIMIDEX(R) (anastrozole) for its ... exclusivity being,granted by the FDA, the patent was due ... approved in the US for the for the following,indications:, ...
Cached Medicine News:Health News:BLU-MED Announces New Medical Preparedness Contracts 2Health News:Cancer Patients Gain From Reporting Symptoms Online 2Health News:Omnicell Announces Agreement to Acquire Rioux Vision, Inc. 2Health News:Omnicell Announces Agreement to Acquire Rioux Vision, Inc. 3Health News:Ibuprofen associated with slower lung function decline in children with cystic fibrosis 2Health News:Cavidi Signs Agreement With the Clinton Foundation HIV/AIDS Initiative to Lower Costs of HIV Monitoring 2Health News:Cavidi Signs Agreement With the Clinton Foundation HIV/AIDS Initiative to Lower Costs of HIV Monitoring 3Health News:AstraZeneca Receives Six Months Pediatric Exclusivity Patent Extension for ARIMIDEX(R) (anastrozole) from the FDA 2Health News:AstraZeneca Receives Six Months Pediatric Exclusivity Patent Extension for ARIMIDEX(R) (anastrozole) from the FDA 3
(Date:8/21/2014)... , Aug. 21, 2014   Auxilium ... a specialty biopharmaceutical company, today announced positive results ... collagenase clostridium histolyticum (or CCH) for the treatment ... cellulite. In the Phase 2a trial, all three ... high (0.84mg)) showed an improvement in the appearance ...
(Date:8/20/2014)... Md. , Aug. 20, 2014  The ... lauded the latest results achieved by the real-time, ... as the National Precursor Log Exchange (NPLEx), automatically ... officials track down methamphetamine offenders and make arrests. ... Missouri blocked the sale ...
(Date:8/20/2014)... YORK , Aug. 20, 2014 /PRNewswire/ ... research report is available in its catalogue: ... in France, Key Trends and Opportunities to ... Synopsis The report provides in ... the French personal accident and health insurance ...
Breaking Medicine Technology:Auxilium Pharmaceuticals, Inc. Announces Positive Data From Phase 2a Study Of CCH In Patients With Cellulite 2Auxilium Pharmaceuticals, Inc. Announces Positive Data From Phase 2a Study Of CCH In Patients With Cellulite 3Auxilium Pharmaceuticals, Inc. Announces Positive Data From Phase 2a Study Of CCH In Patients With Cellulite 4Auxilium Pharmaceuticals, Inc. Announces Positive Data From Phase 2a Study Of CCH In Patients With Cellulite 5Auxilium Pharmaceuticals, Inc. Announces Positive Data From Phase 2a Study Of CCH In Patients With Cellulite 6Auxilium Pharmaceuticals, Inc. Announces Positive Data From Phase 2a Study Of CCH In Patients With Cellulite 7Missouri's Stop-Sale System Achieves Significant Results In Battle Against Meth 2Personal Accident and Health Insurance in France, Key Trends and Opportunities to 2018 2Personal Accident and Health Insurance in France, Key Trends and Opportunities to 2018 3Personal Accident and Health Insurance in France, Key Trends and Opportunities to 2018 4Personal Accident and Health Insurance in France, Key Trends and Opportunities to 2018 5Personal Accident and Health Insurance in France, Key Trends and Opportunities to 2018 6Personal Accident and Health Insurance in France, Key Trends and Opportunities to 2018 7Personal Accident and Health Insurance in France, Key Trends and Opportunities to 2018 8Personal Accident and Health Insurance in France, Key Trends and Opportunities to 2018 9Personal Accident and Health Insurance in France, Key Trends and Opportunities to 2018 10Personal Accident and Health Insurance in France, Key Trends and Opportunities to 2018 11Personal Accident and Health Insurance in France, Key Trends and Opportunities to 2018 12Personal Accident and Health Insurance in France, Key Trends and Opportunities to 2018 13Personal Accident and Health Insurance in France, Key Trends and Opportunities to 2018 14Personal Accident and Health Insurance in France, Key Trends and Opportunities to 2018 15Personal Accident and Health Insurance in France, Key Trends and Opportunities to 2018 16Personal Accident and Health Insurance in France, Key Trends and Opportunities to 2018 17Personal Accident and Health Insurance in France, Key Trends and Opportunities to 2018 18Personal Accident and Health Insurance in France, Key Trends and Opportunities to 2018 19Personal Accident and Health Insurance in France, Key Trends and Opportunities to 2018 20Personal Accident and Health Insurance in France, Key Trends and Opportunities to 2018 21Personal Accident and Health Insurance in France, Key Trends and Opportunities to 2018 22Personal Accident and Health Insurance in France, Key Trends and Opportunities to 2018 23
The Emit 2000 Phenytoin Assay is a homogeneous enzyme immunoassay intended for use in the quantitative analysis of phenytoin in human serum or plasma. Emit 2000 assays are designed for use with most ...
Our high quality therapeutic drug monitoring reagents, calibrators and controls are available for most chemistry analyzers. Reproducible and accurate results for your laboratory needs....
The Emit 2000 Digoxin Calibrators are intended for use with the Emit 2000 Digoxin Assay....
... The Newmarket Laboratories RPR kits use ... of lipid antigens, which will combine ... or plasma. The particles are suspended ... eliminate non - specific reactions. Positive ...
Medicine Products: